Developments in Carbohydrate-Based Cancer Therapeutics

Area of Science:

• Biochemistry
• Immunology
• Oncology

Background:

• Aberrant glycosylation in cancer cells leads to overexpression of tumor-specific carbohydrate antigens (TACAs).
• TACAs serve as biomarkers for cancer detection and targets for immunotherapy.
• Tumor cells exhibit altered glucose metabolism, presenting opportunities for targeted therapies.

Purpose of the Study:

• To review recent advancements in carbohydrate-based cancer treatments.
• To highlight the development of synthetic carbohydrate-based antitumor vaccines.
• To discuss glycoconjugation strategies for anticancer drugs and novel diagnostic approaches.

Main Methods:

• Review of recent scientific literature on carbohydrate-based cancer therapies.
• Analysis of synthetic vaccine design targeting TACAs.
• Examination of glycoconjugate prodrugs and glycosidase inhibitors.

Main Results:

• Progress in developing synthetic carbohydrate-based vaccines to enhance anti-tumor immune responses.
• Emerging strategies for glycoconjugation of anticancer drugs, leveraging the Warburg effect.
• Development of glycosidase inhibiting iminosugars for therapeutic intervention.

Conclusions:

• Carbohydrate-based strategies show promise in cancer treatment, including vaccines and targeted drug delivery.
• These approaches offer potential for improved cancer diagnosis and therapy.
• Further research in this area is crucial for clinical translation.